SCHEMBL5720185

SCHEMBL5720185

O=C1[N]c2cc(C3CCN(C4CCN(Cc5cc6ccsc6s5)CC4)CC3)ccc2N1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.34
DRD4 P21917 6/20 0.34
DRD3 P35462 3/20 0.34
TLR9 Q9NR96 6/20 0.33
TLR7 Q9NYK1 6/20 0.33
TLR8 Q9NR97 3/20 0.32
PIM1 P11309 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
PARP1 P09874 2/20 0.32
OPRK1 P41145 1/20 0.32
ALDH1A1 P00352 2/20 0.31
RAB9A P51151 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TRPV6 Q9H1D0 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM3 P20309 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5719999 0.84 CHRM2 (0.45) DRD2DRD4DRD3TLR9TLR7
SCHEMBL5720110 0.82 TLR9 (0.40) DRD2DRD4DRD3TLR9TLR7
SCHEMBL5720128 0.82 TLR7 (0.44) DRD2DRD4DRD3TLR9TLR7
SCHEMBL5720388 0.82 DRD2 (0.40) DRD2DRD4DRD3TLR9TLR7
SCHEMBL5720129 0.81 TLR9 (0.35) DRD2DRD4DRD3TLR9TLR7
SCHEMBL5720167 0.81 TLR9 (0.35) DRD2DRD4DRD3TLR9TLR7
SCHEMBL5720269 0.81 DRD2 (0.39) DRD2DRD4DRD3TLR9TLR7
SCHEMBL5720132 0.76 TRPV6 (0.41) DRD2DRD4DRD3TLR9TLR7
SCHEMBL5720125 0.76 CHRM1 (0.41) DRD2DRD4DRD3TLR9TLR7
SCHEMBL5720279 0.76 DRD2 (0.41) DRD2DRD4DRD3TLR9TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515722-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2006-06-21 EP claimed
EP-1515722-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2005-03-23 EP claimed
WO-2003105781-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2003-12-24 WO claimed
EP-1515722-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2006-06-21 EP disclosed
EP-1515722-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2005-03-23 EP disclosed
WO-2003105781-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2003-12-24 WO disclosed